AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
πΏπΌ
METOCLOPRAMIDE in Zimbabwe
1 product registered with MCAZ β 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| NONE SOLUTION; INJECTION | 2025/16.2/6912 | ARAVAS PHARMACEUTICALS | active | 6 Apr 2030 |
METOCLOPRAMIDE β MCAZ Registration Details
MCAZ (Zimbabwe) has 1 registered product containing METOCLOPRAMIDE, of which 1 is currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track METOCLOPRAMIDE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.